SAB Biotherapeutics, Inc.
Hedge Funds Holdings
Last updated:
SAB Biotherapeutics, Inc.‘s stocks are currently a part of 21 hedge funds’ portfolios, which represents 4.49% of the total amount of its stocks outstanding. This makes up a total of 1.93M shares of SAB Biotherapeutics, Inc.. Compared to the previous quarter, the number fell by -52.82% or -2.16M shares fewer. As for the holding position changes, 19.05% (4) of current hedge fund investors increased the number of shares held, 19.05% (4) of current holders sold a part of the shares held, and 19.05% (4) closed the holdings completely. 3 hedge funds are new holders of SAB Biotherapeutics, Inc. stock in Q1 2023, it is 14.29% of total holders.
Hedge funds holding SAB Biotherapeutics (Q3 2021 – Q1 2023)
| Q3 2021 | 1 |
|---|---|
| Q4 2021 | 34 |
| Q1 2022 | 26 |
| Q2 2022 | 35 |
| Q3 2022 | 35 |
| Q4 2022 | 36 |
| Q1 2023 | 21 |
Hedge funds changes in SAB Biotherapeutics positions (Q3 2021 – Q1 2023)
| Q3 2021 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2021 | 34 | 0 | 0 | 1 | -1 |
| Q1 2022 | 2 | 14 | 6 | 10 | -6 |
| Q2 2022 | 12 | 9 | 7 | 3 | 4 |
| Q3 2022 | 5 | 7 | 6 | 5 | 12 |
| Q4 2022 | 9 | 8 | 7 | 6 | 6 |
| Q1 2023 | 3 | 4 | 4 | 4 | 6 |